# Don S. Fredrickson Lipid Research Conference

> **NIH NIH R13** · UNIVERSITY OF KENTUCKY · 2020 · $17,000

## Abstract

Abstract
The Don S. Fredrickson Lipid Research Conference (formerly the Southeast Lipid Research
Conference (SELRC)) brings together scientists and trainees investigating the impact of lipid and
lipoprotein metabolism on the development and treatment of Cardiometabolic disease. The
conference has been an annual event since 1992, was sponsored by Emory University, and held at
Callaway Gardens, Pine Mountain, GA. SELRC participants were generally located within the
southeastern US, but with the retirement of its founding organizer and the changing landscape of
conference support by industry partners, the board voted to re-envision the conference and developed
an institutional-host model. The first of these partnerships occurred in 2016 at the University of
Kentucky. Since 2016, the SELRC has been hosted by Vanderbilt University and the University of
Cincinnati. Following a return to UK in 2020, the conference will be hosted by Duke University and
the University of North Carolina in 2021 and again at Vanderbilt in 2022.
The move to the institutional-host model resulted in a substantial increase in attendance and a larger
geographical footprint that extended beyond the Southeast. With the blessing of the family, the board
voted to rename the SELRC after the late Don S. Fredrickson. Dr. Fredrickson served as the director
of the National Heart Institute (now the NHLBI) from 1966 – 1974 and later the NIH, developed the
clinical classification for dyslipidemias (Type I-V), described Tangier’s Disease, and made seminal
discoveries in the area of lipoprotein metabolism. Most importantly, he trained both basic and clinical
scientists and practitioners who have had a tremendous impact on the field of lipoprotein metabolism.
Keynote Lectures at the 2020 Fredrickson conference include Ruth McPherson, Ottawa Heart
Institute and Mahmood Hussein, NYU on Days 1 and 3 of the conference. The scientific sessions
include Hepatic and Peripheral Lipid Metabolism, Bioinformatics in Metabolic and CVD Research,
Lipids and Inflammation, and Genetics and Cardiometabolic Disease. Day 2 of the conference will be
sponsored by the UK Cardiovascular Research Center and features the Gill Awards for a senior and
early career investigator as well as a provocative noon hour speaker, Amy Herman, New York Times
best-selling author of “The Art of Perception”. The agenda includes additional scientific sessions;
multiple “Poster Pitch” sessions (5-7, 90-second presentations by trainees) and two judged poster
sessions. The combined agenda affords every trainee in attendance the opportunity to present their
research on stage, network with leaders in the field, and broaden their scope and understanding of
research in Cardiometabolic disease.

## Key facts

- **NIH application ID:** 10069712
- **Project number:** 1R13HL154523-01
- **Recipient organization:** UNIVERSITY OF KENTUCKY
- **Principal Investigator:** Gregory A Graf
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $17,000
- **Award type:** 1
- **Project period:** 2020-09-01 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10069712

## Citation

> US National Institutes of Health, RePORTER application 10069712, Don S. Fredrickson Lipid Research Conference (1R13HL154523-01). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10069712. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*